/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant.
/PRNewswire/ Positive MIV-818 data presented at ESMO. New positive data and renegotiated agreement for remetinostat July – September Financial summary for.
Stockholm, Sweden Medivir AB today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2022.
According to an AGM resolution, the. | October 28, 2021
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in.